GRM7-related disorder: Five additional patients from three independent families and review of the literature.

Developmental and epileptic encephalopathy GRM7 Gene Neurodevelopmental disorder Recessive

Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
07 Dec 2023
Historique:
received: 07 06 2023
revised: 22 10 2023
accepted: 03 12 2023
medline: 10 12 2023
pubmed: 10 12 2023
entrez: 9 12 2023
Statut: aheadofprint

Résumé

Developmental and epileptic encephalopathies (DEEs) refer to a group of severe epileptic syndromes characterized by seizures as well as a developmental delay which can be a consequence of the underlying etiology and/or the epileptic encephalopathy. The genes responsible for DEEs are numerous and their number is increasing since the availability of Next-Generation Sequencing. Pathogenic variants in GRM7, encoding the metabotropic glutamate receptor 7, were recently shown as a cause of a severe DEE with autosomal recessive inheritance. To date, only ten patients have been reported in the literature, generally with severe phenotypes including early-onset epilepsy, microcephaly, brain anomalies, and spasticity. We report here 5 patients from 3 independent families with biallelic variants in the GRM7 gene. We review the literature and provide further elements for the understanding of the genotype-phenotype correlation of this rare syndrome.

Identifiants

pubmed: 38070825
pii: S1769-7212(23)00199-4
doi: 10.1016/j.ejmg.2023.104893
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

104893

Informations de copyright

Copyright © 2023. Published by Elsevier Masson SAS.

Auteurs

Louis Januel (L)

Hospices Civils de Lyon, Groupe Hospitalier Est, Service de Génétique, Bron, France. Electronic address: louis.januel@chu-lyon.fr.

Nicolas Chatron (N)

Hospices Civils de Lyon, Groupe Hospitalier Est, Service de Génétique, Bron, France; Institut NeuroMyoGene PNMG, CNRS UMR5310, INSERM U1217, Université Claude Bernard Lyon 1, Lyon, France.

Clotilde Rivier Ringenbach (C)

Hôpital Nord-Ouest, Service de Neuropédiatre, Villefranche sur Saône, France.

Sara Cabet (S)

Hospices Civils de Lyon, Groupe Hospitalier Est, Service de Radiologie, Bron, France.

Audrey Labalme (A)

Hospices Civils de Lyon, Groupe Hospitalier Est, Service de Génétique, Bron, France.

Yavuz Sahin (Y)

Genoks Genetic Laboratory, Ankara, Turkey.

Hossein Darvish (H)

Pediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ, USA.

Michael Kruer (M)

Pediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ, USA.

Somayeh Bakhtiari (S)

Pediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ, USA.

Damien Sanlaville (D)

Hospices Civils de Lyon, Groupe Hospitalier Est, Service de Génétique, Bron, France; Institut NeuroMyoGene PNMG, CNRS UMR5310, INSERM U1217, Université Claude Bernard Lyon 1, Lyon, France.

Jean Madeleine de Sainte Agathe (JM)

Département de Génétique Médicale, GHU Pitié-Salpêtrière, AP-HP.Sorbonne Université, Paris, France.

Gaetan Lesca (G)

Hospices Civils de Lyon, Groupe Hospitalier Est, Service de Génétique, Bron, France; Institut NeuroMyoGene PNMG, CNRS UMR5310, INSERM U1217, Université Claude Bernard Lyon 1, Lyon, France.

Classifications MeSH